{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T07:55:06Z","timestamp":1789977306407,"version":"4.0.1"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1097\/inf.0b013e3181f4cf69","type":"journal-article","created":{"date-parts":[[2010,8,25]],"date-time":"2010-08-25T03:26:12Z","timestamp":1282706772000},"page":"168-170","source":"Crossref","is-referenced-by-count":46,"title":["PNEUMOCOCCAL MENINGITIS IN FRENCH CHILDREN BEFORE AND AFTER THE INTRODUCTION OF PNEUMOCOCCAL CONJUGATE VACCINE"],"prefix":"10.1097","volume":"30","author":[{"given":"Corinne","family":"Levy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Varon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edouard","family":"Bingen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"L\u00e9cuyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Boucherat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-18-20210202","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1086\/432944","article-title":"Bacterial meningitis in children: a French prospective study.","volume":"41","author":"Bingen","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R2-18-20210202","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1001\/jama.295.14.1668","article-title":"Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine.","volume":"295","author":"Poehling","year":"2006","journal-title":"JAMA"},{"key":"R3-18-20210202","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1086\/648593","article-title":"Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine.","volume":"201","author":"Pilishvili","year":"2010","journal-title":"J Infect Dis"},{"key":"R4-18-20210202","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1542\/peds.2008-1702","article-title":"Serotype 19A is the most common serotype causing invasive pneumococcal infections in children.","volume":"125","author":"Kaplan","year":"2010","journal-title":"Pediatrics"},{"key":"R5-18-20210202","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.diagmicrobio.2009.10.012","article-title":"Epidemiology of pediatric community-acquired bloodstream infections in a children hospital in Paris, France, 2001 to 2008.","volume":"66","author":"Doit","year":"2010","journal-title":"Diagn Microbiol Infect Dis"},{"key":"R6-18-20210202","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s10096-007-0417-y","article-title":"Pneumococcal meningitis in the era of pneumococcal conjugate vaccine implementation.","volume":"27","author":"Bingen","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R7-18-20210202","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1056\/NEJMoa0800836","article-title":"Effect of pneumococcal conjugate vaccine on pneumococcal meningitis.","volume":"360","author":"Hsu","year":"2009","journal-title":"N Engl J Med"},{"key":"R8-18-20210202","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1086\/587897","article-title":"Changing epidemiology of pneumococcal meningitis after the introduction of pneumococcal conjugate vaccine in the United States.","volume":"46","author":"Tsai","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R9-18-20210202","first-page":"33","article-title":"French vaccinal calendar.","volume":"6","year":"2003","journal-title":"Bull Epidemiol Hebd"},{"key":"R10-18-20210202","first-page":"151","article-title":"Evolution of PCV7 coverage in 2006 to 2008: analysis of health records.","author":"Gaudelus","year":"2009","journal-title":"Medecine et Enfance"},{"key":"R11-18-20210202","first-page":"212","article-title":"French vaccinal calendar.","volume":"29-","year":"2006","journal-title":"Bull Epidemiol Hebd"},{"key":"R12-18-20210202","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1128\/JCM.02199-06","article-title":"Discovery of a new capsular serotype (6C) within serogroup 6 of Streptococcus pneumoniae.","volume":"45","author":"Park","year":"2007","journal-title":"J Clin Microbiol"},{"key":"R13-18-20210202","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1086\/598975","article-title":"Rationale for revised penicillin susceptibility breakpoints versus Streptococcus pneumoniae: coping with antimicrobial susceptibility in an era of resistance.","volume":"48","author":"Weinstein","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R14-18-20210202","first-page":"16","article-title":"Evaluation of the surveillance of paediatric pneumococcal meningitis infections in France, 2001\u20132002 by capture-recapture method.","volume":"2-3","author":"Perrocheau","year":"2006","journal-title":"Bull Epidemiol Hebd"},{"key":"R15-18-20210202","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1086\/524660","article-title":"Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine.","volume":"46","author":"Munoz-Almagro","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R16-18-20210202","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1016\/j.vaccine.2009.02.063","article-title":"Epidemiology of pneumococcal meningitis hospitalizations in pediatric population in Spain (1998\u20132006).","volume":"27","author":"Gil Prieto","year":"2009","journal-title":"Vaccine"},{"key":"R18-18-20210202","doi-asserted-by":"crossref","first-page":"4136","DOI":"10.1016\/j.vaccine.2009.04.057","article-title":"Reduction in the incidence of invasive pneumococcal disease after general vaccination with 7-valent pneumococcal conjugate vaccine in Germany.","volume":"27","author":"Ruckinger","year":"2009","journal-title":"Vaccine"},{"key":"R19-18-20210202","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1093\/infdis\/171.4.885","article-title":"Serotype distribution of Streptococcus pneumoniae infections among preschool children in the United States, 1978\u20131994: implications for development of a conjugate vaccine.","volume":"171","author":"Butler","year":"1995","journal-title":"J Infect Dis"},{"key":"R20-18-20210202","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2217\/17460913.3.1.23","article-title":"Serotype-specific problems associated with pneumococcal conjugate vaccination.","volume":"3","author":"Hanage","year":"2008","journal-title":"Future Microbiol"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006454-201102000-00018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:41:23Z","timestamp":1786041683000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006454-201102000-00018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e3181f4cf69","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}